Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

NEW YORK, Oct. 18, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

http://www.reportlinker.com/p0546772/Interventional-Neurology---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData's new report, "Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global interventional neurology market. The report provides market landscape, competitive landscape and market trends information on the interventional neurology market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include Embolic Systems, Navigational Systems, Neurovascular Stents and Aneurysm Clips.

- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within interventional neurology market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Boston Scientific Corporation, Johnson & Johnson, Covidien plc and Terumo Corporation.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the interventional neurology market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next big thing in the interventional neurology market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global interventional neurology market and the factors shaping it.

1 Table of contents

1 Table of contents 3

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction and Overview 9

2.1 Introduction 9

2.2 GlobalData Report Guidance 9

3 Interventional Neurology: Overview 10

3.1 Interventional Neurology: Market Segmentation 10

3.1.1 Embolic systems 11

3.1.2 Navigational Systems 11

3.1.3 Neurovascular Stents 12

3.1.4 Aneurysm Clips 12

4 Aneurysms: Overview 13

4.1 Cerebral Aneurysm 13

4.1.1 Types of Cerebral Aneurysm 13

4.1.2 Causes 14

4.1.3 Pathophysiology 14

4.1.4 Epidemiology 15

4.1.5 Diagnosis 15

5 Interventional Neurology: Global Market Characterization 16

5.1 Interventional Neurology Market, Global, Revenue ($m), Historic, 2003-2010 16

5.2 Interventional Neurology Market, Global, Revenue ($m), Forecast, 2010-2017 17

5.3 Interventional Neurology Market, Key Trends 18

5.3.1 Use of Interventional Neurology Products for Treating Other Diseases is a Emerging Trend in the Market 18

5.3.2 Neuroform Stents 19

5.3.3 Liquid Embolic Systems 19

5.3.4 Acquisitions of Major Interventional Neurology Companies 20

5.4 Interventional Neurology, Market Dynamics 21

5.4.1 Market Drivers 21

5.4.2 Interventional Neurology, Market Restraints 23

6 Interventional Neurology Market, Analysis by Segment 25

6.1 Embolic Systems, Market Characterization 25

6.1.1 Embolic Systems Market, Global, Revenue ($m), Historic, 2003-2010 25

6.1.2 Embolic Systems Market, Global, Revenue ($m), Forecast, 2010-2017 26

6.2 Embolic Systems: Market Dynamics 27

6.2.1 Market Drivers 27

6.2.2 Market Restraint 27

6.3 Navigational Systems: Market Characterization 28

6.3.1 Navigational Systems Market, Global, Revenue ($m), Historic, 2003-2010 28

6.3.2 Navigational Systems Market, Global, Revenue ($m), Forecast, 2010-2017 29

6.4 Navigational Systems: Market Dynamics 30

6.4.1 Market Drivers 30

6.4.2 Market Restraint: 30

6.5 Neurovascular Stents: Market Characterization 31

6.5.1 Neurovascular Stents Market, Global, Revenue ($m), Historic, 2003-2010 31

6.5.2 Neurovascular Stents Market, Global, Revenue ($m), Forecast, 2010-2017 32

6.6 Neurovascular Stents: Market Dynamics 33

6.6.1 Market Driver: Technological Advancements is to Drive the Market 33

6.6.2 Market Restraint: High Risk associated with Stent to Restrain the Market 33

6.7 Aneurysm Clips: Market Characterization 34

6.7.1 Aneurysm Clips Market, Global, Revenue ($m), Historic, 2003-2010 34

6.7.2 Aneurysm Clips Market, Global, Revenue ($m), Forecast, 2010-2017 35

6.8 Aneurysm Clips: Market Dynamics 36

6.8.1 Market Driver: Cost of Treatment Is Driving the Market 36

6.8.2 Market Restraint: Advancements in the Treatment of Aneurysms is a Restraint to the Clipping Market 36

7 Interventional Neurology Market, by Country, Revenue ($m), 2003-2017 37

7.1 Interventional Neurology Market, The US, Revenue ($m), Historic, 2003-2010 37

7.2 Interventional Neurology Market, The US, Revenue ($m), Forecast, 2010-2017 38

7.3 Interventional Neurology Market, Canada, Revenue ($m), Historic, 2003-2010 39

7.4 Interventional Neurology Market, Canada, Revenue ($m), Forecast, 2003-2010 40

7.5 Interventional Neurology Market, The UK, Revenue ($m), Historic, 2003-2010 41

7.6 Interventional Neurology Market, The UK, Revenue ($m), Forecast, 2010-2017 42

7.7 Interventional Neurology Market, Germany, Revenue ($m), Historic, 2003-2010 43

7.8 Interventional Neurology Market, Germany, Revenue ($m), Forecast, 2010-2017 44

7.9 Interventional Neurology Market, France, Revenue ($m), Historic, 2003-2010 45

7.10 Interventional Neurology Market, France, Revenue ($m), Forecast, 2010-2017 46

7.11 Interventional Neurology Market, Italy, Revenue ($m), Historic, 2003-2010 47

7.12 Interventional Neurology Market, Italy, Revenue ($m), Forecast, 2010-2017 48

7.13 Interventional Neurology Market, Spain, Revenue ($m), Historic, 2003-2010 49

7.14 Interventional Neurology Market, Spain, Revenue ($m), Forecast, 2010-2017 50

7.15 Interventional Neurology Market, Japan, Revenue ($m), Historic, 2003-2010 51

7.16 Interventional Neurology Market, Japan, Revenue ($m), Forecast, 2010-2017 52

7.17 Interventional Neurology Market, China, Revenue ($m), Historic, 2003-2010 53

7.18 Interventional Neurology Market, China, Revenue ($m), Forecast, 2010-2017 54

7.19 Interventional Neurology Market, India, Revenue ($m), Historic, 2003-2010 55

7.20 Interventional Neurology Market, India, Revenue ($m), Forecast, 2010-2017 56

7.21 Interventional Neurology Market, Australia, Revenue ($m), Historic, 2003-2010 57

7.22 Interventional Neurology Market, Australia, Revenue ($m), Forecast, 2010-2017 58

7.23 Interventional Neurology Market, Brazil, Revenue ($m), Historic, 2003-2010 59

7.24 Interventional Neurology Market, Brazil, Revenue ($m), Forecast, 2010-2017 60

8 Interventional Neurology Market: Strategic Competitive Assessment 61

8.1 Interventional Neurology: Key Market Participants 62

8.1.1 Boston Scientific Corporation 62

8.1.2 Johnson & Johnson 65

8.1.3 Covidien plc 68

8.1.4 Terumo Corporation 71

9 Interventional Neurology: Key Marketed Products 74

9.1 Neuroform3 Microdelivery Stent System 74

9.1.1 Product Description 74

9.1.2 Features and Benefits 74

9.2 Axium Detachable Coil System 74

9.2.1 Product Description 74

9.2.2 Features and Benefits 74

9.3 Onyx HD-500 75

9.3.1 Product Description 75

9.3.2 Features and Benefits 75

9.4 AZUR Peripheral HydroCoil Embolization System 75

9.4.1 Product Description 75

9.4.2 Features and Benefits 75

9.5 DELTAPAQ Microcoils 76

9.5.1 Product Description 76

9.5.2 Features and Benefits 76

10 Interventional Neurology Market: Strategic Pipeline Assessment 77

10.1 Interventional Neurology Products under Clinical Development 78

10.1.1 GORE Embolic Filter 78

10.1.2 Restore Microcatheter 79

10.1.3 PHAROS Vitesse Stent 80

10.1.4 Neucrylate AN 83

10.1.5 Solitaire FR Revascularization Device 84

10.1.6 Solitaire AB Neurovascular Remodeling Device 88

10.1.7 Transcranial Doppler Ultrasound Device 88

10.2 Interventional Neurology Products under Early Development 88

10.2.1 AIC Catheter 89

10.2.2 Balloon Expandable Stent - Next Generation 89

10.2.3 Catheter Based System 89

10.2.4 Covered Stent 89

10.2.5 Flow Diverter 89

10.2.6 Liquid Embolic System 89

10.2.7 Neuravi Device 89

10.2.8 Occlusion Balloons 89

10.2.9 Self-Expanding Stent 90

10.2.10 TBI Intervention System 90

10.3 Interventional Neurology Products under Pre-Clinical Development 90

10.3.1 Aneurysm Occlusion Device 90

10.3.2 Brain Cooling Device 90

10.3.3 Cerebral Aneurysm Repair Device 90

10.3.4 GP Mechanical Thrombectomy Device 90

10.3.5 NAVIMAX Spiral Balloon Catheter 90

10.3.6 Ultrasound Clot Buster 91

10.4 Interventional Neurology Products in Approval Phase 91

10.4.1 MicruSphere Microcoil 91

10.4.2 Cerecyte Microcoil 93

10.4.3 NeuroFlo Catheter 98

10.4.4 X Calibur Aneurysm Occlusion Device 110

10.4.5 Neucrylate AN 111

10.4.6 Courier Microcatheter 112

10.4.7 HeliPaq 112

10.4.8 HeliPaq SR 112

10.4.9 InterPaq Microcoil 112

10.4.10 UltiPaq Microcoil 112

11 Interventional Neurology Market: Strategic Deals Analysis 113

11.1 Key Acquisitions 114

11.1.1 Stryker Acquires Boston Scientifics' Neurovascular Division 114

11.1.2 Johnson & Johnson Acquires Micrus Endovascular 114

11.1.3 Covidien Completed Acquisition of ev3 for $2.6 Billion 115

12 Appendix 116

12.1 Definitions 117

12.1.1 Interventional Neurology 117

12.1.2 Embolic Systems 117

12.1.3 Navigational Systems 117

12.1.4 Neurovascular Stents 117

12.1.5 Aneurysm Clips 117

12.2 Acronyms 118

12.3 Sources 118

12.4 Research Methodology 119

12.5 Secondary Research 119

12.6 Primary Research 119

12.7 Models 120

12.8 Forecasts 120

12.9 GlobalData Consulting 120

12.10 Contact Us 121

12.11 Disclaimer 121

1.1 List of Tables

Table 1: Interventional Neurology Market, Global, Revenue ($m), 2003-2010 16

Table 2: Interventional Neurology Market, Global, Revenue ($m), 2010-2017 17

Table 3: Major Acquisitions in Interventional Neurology Market 20

Table 4: Embolic Systems Market, Global, Revenue ($m), 2003-2010 25

Table 5: Embolic Systems Market, Global, Revenue ($m), 2010-2017 26

Table 6: Navigational Systems Market, Global, Revenue ($m), 2003-2010 28

Table 7: Navigational Systems Market, Global, Revenue ($m), 2010-2017 29

Table 8: Neurovascular Stents Market, Revenue ($m), 2003-2010 31

Table 9: Neurovascular Stents Market, Revenue ($m), 2010-2017 32

Table 10: Aneurysm Clips Market, Global, Revenue ($m), 2003-2010 34

Table 11: Aneurysm Clips Market, Global, Revenue ($m), 2010-2017 35

Table 12: Interventional Neurology Market, The US, Revenue ($m), 2003-2010 37

Table 13: Interventional Neurology Market, The US, Revenue ($m), 2010-2017 38

Table 14: Interventional Neurology Market, Canada, Revenue ($m), 2003-2010 39

Table 15: Interventional Neurology Market, Canada, Revenue ($m), 2010-2017 40

Table 16: Interventional Neurology Market, the UK, Revenue ($m), 2003-2010 41

Table 17: Interventional Neurology Market, The UK, Revenue ($m), 2010-2017 42

Table 18: Interventional Neurology Market, Germany, Revenue ($m), 2003-2010 43

Table 19: Interventional Neurology Market, Germany, Revenue ($m), 2010-2017 44

Table 20: Interventional Neurology Market, France, Revenue ($m), 2003-2010 45

Table 21: Interventional Neurology Market, France, Revenue ($m), 2010-2017 46

Table 22: Interventional Neurology Market, Italy, Revenue ($m), 2003-2010 47

Table 23: Interventional Neurology Market, Italy, Revenue ($m), 2010-2017 48

Table 24: Interventional Neurology Market, Spain, Revenue ($m), 2003-2010 49

Table 25: Interventional Neurology Market, Spain, Revenue ($m), 2010-2017 50

Table 26: Interventional Neurology Market, Japan, Revenue ($m), 2003-2010 51

Table 27: Interventional Neurology Market, Japan, Revenue ($m), 2010-2017 52

Table 28: Interventional Neurology Market, China, Revenue ($m), 2003-2010 53

Table 29: Interventional Neurology Market, China, Revenue ($m), 2010-2017 54

Table 30: Interventional Neurology Market, India, Revenue ($m), 2003-2010 55

Table 31: Interventional Neurology Market, India, Revenue ($m), 2010-2017 56

Table 32: Interventional Neurology Market, Australia, Revenue ($m), 2003-2010 57

Table 33: Interventional Neurology Market, Australia, Revenue ($m), 2010-2017 58

Table 34: Interventional Neurology Market, Brazil, Revenue ($m), 2003-2010 59

Table 35: Interventional Neurology Market, Brazil, Revenue ($m), 2010-2017 60

Table 36: Interventional Neurology Market, Company Share (%), 2010 61

Table 37: Boston Scientific Corporation, Marketed Products 62

Table 38: Johnson and Johnson, Marketed Products 65

Table 39: Johnson & Johnson, Pipeline Products 66

Table 40: Covidien, Inc, Marketed Products 68

Table 41: Covidien, Inc, Pipeline Products 68

Table 42: Terumo Corporation, Marketed Products 71

Table 43: Neuroform Microdelivery Stent System, Features and Benefits 74

Table 44: Axium Detachable Coil System, Features and Benefits 74

Table 45: Onyx HD-500, Features and Benefits 75

Table 46: AZUR Peripheral HydroCoil Embolization System, Features and Benefits 75

Table 47: DELTAPAQ Microcoils, Features and Benefits 76

Table 48: Interventional Neurology, Products Under Clinical Development, 2011 78

Table 49: GORE Embolic Filter, Product Status, 2011 78

Table 50: GORE Embolic Filter, Clinical Trials, 2011 79

Table 51: Restore Microcatheter, Product Status, 2011 79

Table 52: Restore Microcatheter, Clinical Trial, 2011 80

Table 53: PHAROS Vitesse Stent, Product Status, 2011 80

Table 54: PHAROS Vitesse Stent, Clinical Trial, 2011 81

Table 55: Neucrylate AN, Product Status, 2011 83

Table 56: Neucrylate AN, Clinical Trial, 2011 83

Table 57: Solitaire FR Revascularization Device, Product Status, 2011 84

Table 58: Solitaire FR Revascularization Device, Clinical Trial (0), 2011 85

Table 59: Solitaire FR Revascularization Device, Clinical Trial (1), 2011 86

Table 60: Interventional Neurology, Products Under Early Development, 2011 88

Table 61: Interventional Neurology, Products Under Pre-Clinical Development, 2011 90

Table 62: Interventional Neurology, Products in Approval Phase, 2011 91

Table 63: MicruSphere Microcoil, Product Status, 2011 91

Table 64: MicruSphere Microcoil, Clinical Trials, 2011 92

Table 65: Cerecyte Microcoil, Clinical Trial(0), 2011 93

Table 66: Cerecyte Microcoil, Clinical Trial(1), 2011 94

Table 67: Cerecyte Microcoil, Clinical Trial(2), 2011 95

Table 68: Cerecyte Microcoil, Clinical Trial(3), 2011 96

Table 69: Cerecyte Microcoil, Clinical Trial(4), 2011 97

Table 70: NeuroFlo Catheter, Product Status, 2011 98

Table 71: NeuroFlo Catheter, Clinical Trial (0), 2011 99

Table 72: NeuroFlo Catheter, Clinical Trial (1), 2011 100

Table 73: NeuroFlo Catheter, Clinical Trial (2), 2011 101

Table 74: NeuroFlo Catheter, Clinical Trial (3), 2011 103

Table 75: NeuroFlo Catheter, Clinical Trial (4), 2011 104

Table 76: NeuroFlo Catheter, Clinical Trial (5), 2011 106

Table 77: NeuroFlo Catheter, Clinical Trial (6), 2011 107

Table 78: NeuroFlo Catheter, Clinical Trial (7), 2011 108

Table 79: NeuroFlo Catheter, Clinical Trial (8), 2011 109

Table 80: X Calibur Aneurysm Occlusion Device, Product Status, 2011 110

Table 81: X Calibur Aneurysm Occlusion Device, Clinical Trials, 2011 111

Table 82: Neucrylate AN, Product Status, 2011 111

Table 83: Interventional Neurology Market, Deal Value ($m) and Volume, 2004 – 2010 113

1.2 List of Figures

Figure 1: Interventional Neurology, Market Segmentation 10

Figure 2: Embolization Coils Procedure 11

Figure 3: Aneurysm Clipping Procedure 12

Figure 4: Types of Cerebral Aneurysms 13

Figure 5: Cerebral Aneurysm, Pathophysiology 14

Figure 6: Cerebral Aneurysm, Disease Burden, 2008 15

Figure 7: Interventional Neurology Market, Global, Revenue ($m), 2003-2010 16

Figure 8: Interventional Neurology Market, Global, Revenue ($m), 2010-2017 17

Figure 9: Interventional Neurology Treatment, by Disease 18

Figure 10: Interventional Neurology, Market Dynamics 21

Figure 11: Embolic Systems Market, Global, Revenue ($m), 2003-2010 25

Figure 12: Embolic Systems Market, Global, Revenue ($m), 2010-2017 26

Figure 13: Navigational Systems Market, Global, Revenue ($m), 2003-2010 28

Figure 14: Navigational Systems Market, Global, Revenue ($m), 2010-2017 29

Figure 15: Neurovascular Stents Market, Revenue ($m), 2003-2010 31

Figure 16: Neurovascular Stents Market, Revenue ($m), 2010-2017 32

Figure 17: Aneurysm Clips Market, Global, Revenue ($m), 2003-2010 34

Figure 18: Aneurysm Clips Market, Global, Revenue ($m), 2010-2017 35

Figure 19: Interventional Neurology Market, The US, Revenue ($m), 2003-2010 37

Figure 20: Interventional Neurology Market, The US, Revenue ($m), 2010-2017 38

Figure 21: Interventional Neurology Market, Canada, Revenue ($m), 2003-2010 39

Figure 22: Interventional Neurology Market, Canada, Revenue ($m), 2010-2017 40

Figure 23: Interventional Neurology Market, The UK, Revenue ($m), 2003-2010 41

Figure 24: Interventional Neurology Market, The UK, Revenue ($m), 2010-2017 42

Figure 25: Interventional Neurology Market, Germany, Revenue ($m), 2003-2010 43

Figure 26: Interventional Neurology Market, Germany, Revenue ($m), 2010-2017 44

Figure 27: Interventional Neurology Market, France, Revenue ($m), 2003-2010 45

Figure 28: Interventional Neurology Market, France, Revenue ($m), 2010-2017 46

Figure 29: Interventional Neurology Market, Italy, Revenue ($m), 2003-2010 47

Figure 30: Interventional Neurology Market, Italy, Revenue ($m), 2010-2017 48

Figure 31: Interventional Neurology Market, Spain, Revenue ($m), 2003-2010 49

Figure 32: Interventional Neurology Market, Spain, Revenue ($m), 2010-2017 50

Figure 33: Interventional Neurology Market, Japan, Revenue ($m), 2003-2010 51

Figure 34: Interventional Neurology Market, Japan, Revenue ($m), 2010-2017 52

Figure 35: Interventional Neurology Market, China, Revenue ($m), 2003-2010 53

Figure 36: Interventional Neurology Market, China, Revenue ($m), 2010-2017 54

Figure 37: Interventional Neurology Market, India, Revenue ($m), 2003-2010 55

Figure 38: Interventional Neurology Market, India, Revenue ($m), 2010-2017 56

Figure 39: Interventional Neurology Market, Australia, Revenue ($m), 2003-2010 57

Figure 40: Interventional Neurology Market, Australia, Revenue ($m), 2010-2017 58

Figure 41: Interventional Neurology Market, Brazil, Revenue ($m), 2003-2010 59

Figure 42: Interventional Neurology Market, Brazil, Revenue ($m), 2010-2017 60

Figure 43: Interventional Neurology Market, Company Share (%), 2010 61

Figure 44: Boston Scientific, SWOT Analysis 63

Figure 45: Johnson & Johnson, SWOT Analysis 66

Figure 46: Covidien, Inc, SWOT Analysis 69

Figure 47: Terumo Corporation, SWOT Analysis 72

Figure 48: Interventional Neurology Market, Global Pipeline Products 77

Figure 49: Interventional Neurology Market, Deal Value ($m) and Volume, 2004 – 2010 113

Companies Mentioned

Boston Scientific Corporation

Johnson & Johnson

Covidien plc

Terumo Corporation

To order this report:

: Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker